home.social

#drugdesign — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #drugdesign, aggregated by home.social.

fetched live
  1. Bioinformatics Scientist - Fully Remote
    micro1

    Bioinformatics scientists (MSc or PhD) needed for fully remote contract work (up to $120/hour!). Ideally looking for experience in medicinal chemistry

    See the full job description on jobRxiv: jobrxiv.org/job/micro1-27778-b

    ...
    jobrxiv.org/job/micro1-27778-b

  2. Ah, the Isomorphic Labs Drug Design Engine, where buzzwords frolic in a field of unfulfilled promises 🌸! They've apparently "unlocked" the future of medicine using mind-reading computers 🧙‍♂️🔮, but can't even unlock the mystery of writing a coherent sentence. Spoiler alert: it's just #AlphaFold with a fancy hat. 🎩
    isomorphiclabs.com/articles/th #IsomorphicLabs #DrugDesign #FutureOfMedicine #TechBuzzwords #HackerNews #ngated

  3. Ah, the Isomorphic Labs Drug Design Engine, where buzzwords frolic in a field of unfulfilled promises 🌸! They've apparently "unlocked" the future of medicine using mind-reading computers 🧙‍♂️🔮, but can't even unlock the mystery of writing a coherent sentence. Spoiler alert: it's just #AlphaFold with a fancy hat. 🎩
    isomorphiclabs.com/articles/th #IsomorphicLabs #DrugDesign #FutureOfMedicine #TechBuzzwords #HackerNews #ngated

  4. Ah, the Isomorphic Labs Drug Design Engine, where buzzwords frolic in a field of unfulfilled promises 🌸! They've apparently "unlocked" the future of medicine using mind-reading computers 🧙‍♂️🔮, but can't even unlock the mystery of writing a coherent sentence. Spoiler alert: it's just #AlphaFold with a fancy hat. 🎩
    isomorphiclabs.com/articles/th #IsomorphicLabs #DrugDesign #FutureOfMedicine #TechBuzzwords #HackerNews #ngated

  5. Ah, the Isomorphic Labs Drug Design Engine, where buzzwords frolic in a field of unfulfilled promises 🌸! They've apparently "unlocked" the future of medicine using mind-reading computers 🧙‍♂️🔮, but can't even unlock the mystery of writing a coherent sentence. Spoiler alert: it's just #AlphaFold with a fancy hat. 🎩
    isomorphiclabs.com/articles/th #IsomorphicLabs #DrugDesign #FutureOfMedicine #TechBuzzwords #HackerNews #ngated

  6. #SaarlandUniversity Professor Andreas Keller and his team receive $9 million in funding to uncover age, sex, and environment related patterns affecting Parkinson's disease progression. They aim to find patterns allowing better individual therapies for patients. 👏

    🔗 Read more: sic.link/aiparkinson

    #bioinformatics #saarlandinformaticscampus #sic #uds #computerscience #drugdesign #parkinsons #CollaborativeResearchNetwork

  7. Polymers' Fuzzy Logic: Function Over Flawless Design

    Virginia Tech study finds polymer composition is key to protein function, not just exact sequence. This changes biomaterial and drug design.

    #PolymerScience, #ProteinFunction, #DrugDesign, #Biomaterials, #VirginiaTech

    newsletter.tf/polymer-composit

  8. Scientists found that the overall makeup of polymers is more important for protein function than the exact order of their parts. This is different from what was thought before.

    #PolymerScience, #ProteinFunction, #DrugDesign, #Biomaterials, #VirginiaTech
    newsletter.tf/polymer-composit

  9. 🎉 Behold, the grand #revelation that molecules need to "actually work" in drug design! 🤯 After weeks of pestering friends with basic questions, our brave guide is ready to enlighten us all with his newfound wisdom. 🤦‍♂️ Apparently, machine learning might just be the solution to everything... who knew? 🧠💥
    magnusross.github.io/posts/pro #drugdesign #machinelearning #scienceinnovation #healthtech #HackerNews #ngated

  10. 🎉 Behold, the grand #revelation that molecules need to "actually work" in drug design! 🤯 After weeks of pestering friends with basic questions, our brave guide is ready to enlighten us all with his newfound wisdom. 🤦‍♂️ Apparently, machine learning might just be the solution to everything... who knew? 🧠💥
    magnusross.github.io/posts/pro #drugdesign #machinelearning #scienceinnovation #healthtech #HackerNews #ngated

  11. 🎉 Behold, the grand #revelation that molecules need to "actually work" in drug design! 🤯 After weeks of pestering friends with basic questions, our brave guide is ready to enlighten us all with his newfound wisdom. 🤦‍♂️ Apparently, machine learning might just be the solution to everything... who knew? 🧠💥
    magnusross.github.io/posts/pro #drugdesign #machinelearning #scienceinnovation #healthtech #HackerNews #ngated

  12. 🎉 Behold, the grand #revelation that molecules need to "actually work" in drug design! 🤯 After weeks of pestering friends with basic questions, our brave guide is ready to enlighten us all with his newfound wisdom. 🤦‍♂️ Apparently, machine learning might just be the solution to everything... who knew? 🧠💥
    magnusross.github.io/posts/pro #drugdesign #machinelearning #scienceinnovation #healthtech #HackerNews #ngated

  13. New paper published in Communications Chemistry with the
    Qubit Pharmaceuticals team led by N. Ansari: "Dual-LAO for calculating fast and robust relative binding free energies of simple and complex transformations"(#Openaccess). #compchem #drugdesign
    F. Aviat, J. Hénin L. Lagardère.
    nature.com/articles/s42004-026

  14. New paper published in Communications Chemistry with the
    Qubit Pharmaceuticals team led by N. Ansari: "Dual-LAO for calculating fast and robust relative binding free energies of simple and complex transformations"(#Openaccess). #compchem #drugdesign
    F. Aviat, J. Hénin L. Lagardère.
    nature.com/articles/s42004-026

  15. New paper published in Communications Chemistry with the
    Qubit Pharmaceuticals team led by N. Ansari: "Dual-LAO for calculating fast and robust relative binding free energies of simple and complex transformations"(#Openaccess). #compchem #drugdesign
    F. Aviat, J. Hénin L. Lagardère.
    nature.com/articles/s42004-026

  16. New paper published in Communications Chemistry with the
    Qubit Pharmaceuticals team led by N. Ansari: "Dual-LAO for calculating fast and robust relative binding free energies of simple and complex transformations"(#Openaccess). #compchem #drugdesign
    F. Aviat, J. Hénin L. Lagardère.
    nature.com/articles/s42004-026

  17. europesays.com/ch/50541/ Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment #DrugDesign #DrugDiscovery #Novartis #Oncology #WorkingAtNovartis

  18. The Coordinated Action “Diagnostic, Therapeutic and Vaccine Viral Targets” of #ANRS MIE is organising a #webinar on #AI for molecular discovery. This webinar will explore how AI and #computational #modelling are advancing #drugdesign and protein research.
    Speakers will present approaches for molecular design, prediction of protein variant effects and dynamics, and structural modelling of protein–protein interactions. The session will also take a critical perspective, addressing current limitations in #cheminformatics and practical considerations for researchers.

    🚨 TOMORROW🚨
    ⚠️ AI for molecular discovery: From drug design to protein dynamics⚠️
    April 15th 2026
    12:30 - 14:00
    Wednesday April 15th 2026, from 12:30 to 14:00 — online (Zoom)

    Programme :

    1️⃣ "AI for drug design" — Dragos Horvath, Strasbourg University
    2️⃣ "Computational approaches for protein variant effect and motion prediction" — Elodie Laine, Sorbonne University
    3️⃣ "Structural modelling and binding affinity prediction of the Human PDZ-PBM interactome" — Victor Reys, Utrecht University

    ➡️ Registration : services.hosting.augure.com/Re

  19. ⚛️ Can we design drugs that stabilize biomolecular interactions instead of blocking them?

    🔗 In Silico Analysis of Potential Stabilizer Binding Sites at Protein–RNA Interfaces. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0016

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #StructuralBiology #DrugDiscovery #ComputationalBiology #RNA #MolecularBiology #Bioinformatics #DrugDesign #SystemsBiology #MedicinalChemistry

  20. ⚛️ Can we design drugs that stabilize biomolecular interactions instead of blocking them?

    🔗 In Silico Analysis of Potential Stabilizer Binding Sites at Protein–RNA Interfaces. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0016

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #StructuralBiology #DrugDiscovery #ComputationalBiology #RNA #MolecularBiology #Bioinformatics #DrugDesign #SystemsBiology #MedicinalChemistry

  21. ⚛️ Can we design drugs that stabilize biomolecular interactions instead of blocking them?

    🔗 In Silico Analysis of Potential Stabilizer Binding Sites at Protein–RNA Interfaces. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0016

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #StructuralBiology #DrugDiscovery #ComputationalBiology #RNA #MolecularBiology #Bioinformatics #DrugDesign #SystemsBiology #MedicinalChemistry

  22. ⚛️ Can we design drugs that stabilize biomolecular interactions instead of blocking them?

    🔗 In Silico Analysis of Potential Stabilizer Binding Sites at Protein–RNA Interfaces. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0016

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #StructuralBiology #DrugDiscovery #ComputationalBiology #RNA #MolecularBiology #Bioinformatics #DrugDesign #SystemsBiology #MedicinalChemistry

  23. New server, new #introduction

    Hi, I'm Dave. I'm a Research #Scientist at a Research Institute in #London, #UK

    I'm a #StructuralBiologist by training. I help run a group that studies #Kinase #signalling in human #health and #disease.

    In my spare time I take photos, play #bass and walk #dogs.

    I do #Crystallography #CryoEM #Biophysics #DrugDesign and #Glycobiology. #Science #Research

  24. New server, new #introduction

    Hi, I'm Dave. I'm a Research #Scientist at a Research Institute in #London, #UK

    I'm a #StructuralBiologist by training. I help run a group that studies #Kinase #signalling in human #health and #disease.

    In my spare time I take photos, play #bass and walk #dogs.

    I do #Crystallography #CryoEM #Biophysics #DrugDesign and #Glycobiology. #Science #Research

  25. New server, new #introduction

    Hi, I'm Dave. I'm a Research #Scientist at a Research Institute in #London, #UK

    I'm a #StructuralBiologist by training. I help run a group that studies #Kinase #signalling in human #health and #disease.

    In my spare time I take photos, play #bass and walk #dogs.

    I do #Crystallography #CryoEM #Biophysics #DrugDesign and #Glycobiology. #Science #Research

  26. New server, new #introduction

    Hi, I'm Dave. I'm a Research #Scientist at a Research Institute in #London, #UK

    I'm a #StructuralBiologist by training. I help run a group that studies #Kinase #signalling in human #health and #disease.

    In my spare time I take photos, play #bass and walk #dogs.

    I do #Crystallography #CryoEM #Biophysics #DrugDesign and #Glycobiology. #Science #Research

  27. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  28. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  29. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  30. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  31. 🧬 How can new AI architectures accelerate the path from molecule to medicine?

    🔗 MM-DRPNet: A multimodal dynamic radial partitioning network for enhanced protein–ligand binding affinity prediction. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2024.11

    📚 CSBJ: csbj.org/

    #StructuralBiology #ProteinLigandInteraction #DrugDesign #ComputationalChemistry #DrugDiscovery #ComputationalBiology #Bioinformatics #MachineLearning #ArtificialIntelligence

  32. 🧬 How can new AI architectures accelerate the path from molecule to medicine?

    🔗 MM-DRPNet: A multimodal dynamic radial partitioning network for enhanced protein–ligand binding affinity prediction. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2024.11

    📚 CSBJ: csbj.org/

    #StructuralBiology #ProteinLigandInteraction #DrugDesign #ComputationalChemistry #DrugDiscovery #ComputationalBiology #Bioinformatics #MachineLearning #ArtificialIntelligence

  33. 🧬 Can AI build peptides that tell your cells to fight back against oxidative stress?

    🔗 RoseTTAFold diffusion-guided short peptide design: a case study of binders against Keap1/Nrf2. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.02

    📚 CSBJ: csbj.org/

    #StructuralBiology #PeptideTherapeutics #RoseTTAFold #ProteinEngineering #MolecularDynamics #AIinDrugDiscovery #AntioxidantResearch #DrugDesign #Bioinformatics #ComputationalBiology

  34. 🧬 Can AI build peptides that tell your cells to fight back against oxidative stress?

    🔗 RoseTTAFold diffusion-guided short peptide design: a case study of binders against Keap1/Nrf2. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.02

    📚 CSBJ: csbj.org/

    #StructuralBiology #PeptideTherapeutics #RoseTTAFold #ProteinEngineering #MolecularDynamics #AIinDrugDiscovery #AntioxidantResearch #DrugDesign #Bioinformatics #ComputationalBiology

  35. "Mô hình AI NucleusDiff mới suppressed коллегиfeitos Julien heal, ngăn cản c COLUMNначальный এ কার Sofa atomic tr 충돌 (100% giảm) và tăng khả năng l Había 22.16% so với mô hình hiện tại. Ứng dụng vào thiết kế dược phẩm dựa trên cấu trúc, đây là bước tiến trongielleicht. Tags: #AI #drugdesign #machinelearning #pharmaceutical #NucleusDiff"

    reddit.com/r/singularity/comme

  36. Another study! Now on computational design of anthraquinone-based, heavy-atom-free photosensitizers for two-photon #PDT in hypoxic tumors.

    4 leads → Type I / II / III / broad-spectrum 🌟

    🔗 doi.org/10.26434/chemrxiv-2025

    #Chemistry #Photonics #CancerResearch #DrugDesign

  37. Another study! Now on computational design of anthraquinone-based, heavy-atom-free photosensitizers for two-photon #PDT in hypoxic tumors.

    4 leads → Type I / II / III / broad-spectrum 🌟

    🔗 doi.org/10.26434/chemrxiv-2025

    #Chemistry #Photonics #CancerResearch #DrugDesign

  38. Another study! Now on computational design of anthraquinone-based, heavy-atom-free photosensitizers for two-photon #PDT in hypoxic tumors.

    4 leads → Type I / II / III / broad-spectrum 🌟

    🔗 doi.org/10.26434/chemrxiv-2025

    #Chemistry #Photonics #CancerResearch #DrugDesign